Bjørn Holmøy
Biographic Data
| ID | 2788854 |
|---|---|
| NAME | Bjørn Holmøy |
| GIVEN NAMES | Bjørn |
| FAMILY NAME | Holmøy |
| SIGNATURE | HOLMØY B |
| AFFILIATIONS | Oslo University Hospital |
| ORCID | 0009-0008-2166-1760 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Assessment of psychedelic--induced states
BackgroundPrevious international clinical trials have indicated that mystical experiences resulting from the consumption of classic psychedelic drugs, such as psilocybin, may represent a subjective psychological mechanism of action associated with therapeutic effects for various mental disorders. The revised 30-item Mystical Experience Questionnaire is one of several psychometric scales designed to evaluate such subjective experiences induced by …
Have Norwegians tried psilocybin, and do they accept it as a medicine
BackgroundPsilocybin is emerging as a promising therapeutic agent for a wide range of psychiatric conditions, and clinical trials on psilocybin-assisted treatment are forthcoming in Scandinavian countries. However, little is known about attitudes towards this psychedelic compound among the general public in Nordic countries. This might represent a confound, and reduce the validity of research findings or the overall feasibility of conducting high…
No prominent works on this page.
Have Norwegians tried psilocybin, and do they accept it as a medicine
BackgroundPsilocybin is emerging as a promising therapeutic agent for a wide range of psychiatric conditions, and clinical trials on psilocybin-assisted treatment are forthcoming in Scandinavian countries. However, little is known about attitudes towards this psychedelic compound among the general public in Nordic countries. This might represent a confound, and reduce the validity of research findings or the overall feasibility of conducting high…
Assessment of psychedelic--induced states
BackgroundPrevious international clinical trials have indicated that mystical experiences resulting from the consumption of classic psychedelic drugs, such as psilocybin, may represent a subjective psychological mechanism of action associated with therapeutic effects for various mental disorders. The revised 30-item Mystical Experience Questionnaire is one of several psychometric scales designed to evaluate such subjective experiences induced by …
Chemical synthesis and alkaloids (2 works) · Clinical Psychology (2 works) · Hallucinogen (2 works) · Norwegian (2 works) · Psilocybin (2 works) · Psychedelics and Drug Studies (2 works) · Psychiatry (2 works) · Psychology (2 works) · Applied Psychology (1 work) · Clinical trial (1 work)